期刊文献+

高血压患者血浆同型半胱氨酸水平及亚甲基四氢叶酸还原酶基因多态性的研究 被引量:17

Study of Plasma Homocysteine Levels and Methylenetetrahydrofolate Reductase Gene Polymorphism in Patients with Hypertension
暂未订购
导出
摘要 目的探讨高血压患者血浆同型半胱氨酸(Hcy)水平及亚甲基四氢叶酸还原酶(MTHFR)A1298C基因多态性对血浆Hcy水平的影响。方法选择原发性高血压患者145例,采用荧光偏振免疫法测定血浆Hcy水平,依据Hcy水平将研究对象分为H型高血压组及非H型高血压组。并应用聚合酶链反应-限制性内切酶片段长度多态性技术检测MTHFR基因多态性。结果 H型高血压组及非H型高血压组血浆平均Hcy水平分别为(16.74±6.14)μmol/L,(8.50±1.02)μmol/L,两者差异有统计学意义(P<0.05)。H型高血压组及非H型高血压组MTHFRA1298C多态位点AA、AC及CC基因型频率分布及C等位基因频率差异均无统计学意义(P>0.05)。AA、AC和CC 3种基因型间的平均血浆Hcy水平比较差异无统计学意义(P<0.05)。结论 H型高血压患者血浆Hcy水平较非H型高血压显著升高,MTHFR A1298C多态位点对血浆Hcy水平无明显影响。 Objective To investigate homocysteine levels in patients with hypertension and the relationship between plasma homocysteine(Hcy) and methylenetetrahydrofolate reductase(MTHFR)gene polymorphisms.Methods 145 hypertension patients were selected.Plasma Hcy was measured by fluorescence polarization immunoassay(FPIA).Acording to the homocysteine levels,the patients were divided into H-type hypertension group and common hypertension group.Polymorphisms of the MTHFR gene were measured by Polymerase chain reaction and restriction fragment length polymorphism(PCR-RFLP).Results Plasma homocysteine levels was significantly higher in H-type hypertension group than in common hypertension group((16.74±6.14)μmol/L VS(8.50±1.02)μmol/L,P0.05).The genotype distribution frequencies of MTHFR A1298C between the two groups were not significant differences(P0.05).Homocysteine levels were not significant different among the three genotype AA,AC and CC(P0.05).Conclusion Hmocysteine level was significantly higher in H-type hypertension group than in common hypertension group.MTHFR A1298C mutation has no significant effect on plasma homocysteine levels.
出处 《实用心脑肺血管病杂志》 2012年第5期777-779,共3页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 高血压 同型半胱氨酸 亚甲基四氢叶酸还原酶 基因 Hypertension Homocysteine Methylenetetrahydrofolate reductase Genes
  • 相关文献

参考文献12

  • 1胡大一,徐希平.有效控制“H型”高血压——预防卒中的新思路[J].中华内科杂志,2008,47(12):976-977. 被引量:750
  • 2Eikelboom JW,Hankey GJ,Anand SS. Association between homocysteine and ischemic stroke due to large-and small-artery disease but not other rtiologic subtype of ischemic stroke[J].Stroke,2000,(05):1069-1075.
  • 3《中国高血压防治指南修订》委员会.中国高血压防治指南(2005修订版)[M]北京:人民卫生出版社,2005.
  • 4Hanson NQ,Aras O,Yang F. C677T and A1298C polymorphism of the methylenetetrahydrofolate reductase gene:incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease[J].Clinical Chemistry,2001,(04):661-666.
  • 5Trabetti E. Homocysteine,MTHFR gene polymorphisms,and cardio-cerebrovascular risk[J].Journal of Applied Genetics,2008,(03):267-282.doi:10.1007/BF03195624.
  • 6李建平,霍勇,刘平,秦献辉,关德明,葛均波,胡健,王燕妮,张馥敏,毛广运,徐希平.马来酸依那普利叶酸片降压、降同型半胱氨酸的疗效和安全性[J].北京大学学报(医学版),2007,39(6):614-618. 被引量:394
  • 7Postnov AI,Goncharova LN,Khasanova ZB. Study of the genetic markers of thrombosis in hypertensive patients of the native population in the Republic of Mordovia[J].Arkhiv Patologii,2009,(04):34-37.
  • 8Homocysteine Lowering Trialists′ Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine:a meta-analysis of the randomized trials[J].American Journal of Clinical Nutrition,2005,(04):806-812.
  • 9Yamada K,Chen Z,Rozen R. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase[J].Proceedings of the National Academy of Sciences(USA),2001,(26):14853-14858.
  • 10Moller J,Nielsen GM,Tvedegaard KC. A meta-analysis of cerebrovascular disease and hyperhomocysteinemia[J].Scandinavian Journal of Clinical and Laboratory Investigation,2000,(06):491-500.

二级参考文献15

  • 1血脂康调整血脂对冠心病二级预防研究协作组.中国冠心病二级预防研究[J].中华心血管病杂志,2005,33(2):109-115. 被引量:224
  • 2刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2611
  • 3Lonn E,Yusuf S,Arnold MJ,菅鑫妍.血管疾病中叶酸和B族维生素的使用不能降低高半胱氨酸浓度[J].中国处方药,2006,5(6):23-24. 被引量:136
  • 4顾东风,Jiang He,吴锡桂,段秀芳,姚崇华,王家良,Kristi Reynolds,Chung-Shiuan Chen,Michael J.Klag,Paul K.Whelton.中国成年人主要死亡原因及其危险因素[J].中国慢性病预防与控制,2006,14(3):149-154. 被引量:76
  • 5Bostom AG, Silbershatz H, Rosenberg IH, et al. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med, 1999, 159:1077-1080.
  • 6Selhub J, Jacques PF, Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA, 1993,270:2693-2698.
  • 7Leclerc D, Campeau E, Goyette P, et al. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet, 1996, 5:1867-1874.
  • 8Van der Put NM, Gabreels F, Stevens EM, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet, 1998, 62:1044-1051.
  • 9Friedman G, Goldschmidt N, Friedlander Y, et al. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr, 1999, 129: 1656-1661.
  • 10Kruger WD, Evans AA, Wang LQ, et al. Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid. Mol Genet Metab, 2000, 70:53-60.

共引文献957

同被引文献184

引证文献17

二级引证文献140

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部